The IPO Buzz: Zenas BioPharma (ZBIO) Prices Upsized IPO at $17.00 Mid-Point

Zenas BioPharma (ZBIO) upsized its IPO at pricing to 13.24 million shares (13,235,294 shares) - up from 11.76 million shares in the prospectus - and priced its IPO at $17.00 - the mid-point of its $16.00-to-$18.00 price range - to raise $225.0 million on Thursday night, Sept. 12, 2024. At pricing, Zenas BioPharma increased the IPO's number of shares by 12.55 percent. Zenas BioPharma's stock opened..

Read more September 13, 2024

IPO Calendar

Company Symbol proposed Lead Managers Shares (Millions) Price Low Price High Est. $ Volume Expected to Trade SCOOP Rating Rating Change
Bicara Therapeutics BCAX Morgan Stanley/ TD Cowen/ Cantor/ Stifel 17.5 18.00 18.00 $ 315.0 mil 9/13/2024 Priced S/O S/O
MBX Biosciences MBX JPMorgan/ Jefferies/ Stifel/ Guggenheim Securities 10.2 16.00 16.00 $ 163.2 mil 9/13/2024 Priced S/O S/O
Zenas BioPharma Inc. ZBIO Morgan Stanley/ Jefferies/ Citigroup/ Guggenheim Securities 13.2 17.00 17.00 $ 225.0 mil 9/13/2024 Priced S/O S/O
Read more

Last 100 IPOs - September 14, 2024

Number of IPOs priced : 100
Number Up: 49
Number Down: 49
Number Unchanged: 2
Percentage Change From Issue Price: 8.61%
Percentage Change for The Nasdaq Composite -100.00%

2024 IPO Scorecard - September 14, 2024

Number of IPOs priced (Excluding 32 units) : 115
Number Up: 55
Number Down: 58
Number Unchanged: 2
Total Return From Issue Price: 9.37%
The Nasdaq Composite Index YTD % Change -100.00%